Kazunori Kawamura1、Tomoteru Yamasaki1、Atsuto Hiraishi1、Masayuki Fujinaga1、Yusuke Kurihara1,2、Masanao Ogawa1,2、Kaito Tsukagoe1,2、Nobuki Nengaki1,2、Lin Xie1、Ming-Rong Zhang1 (1.Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan、2.SHI Accelerator Service Ltd., Tokyo, Japan)
Session information
[JSNM]Radiopharmaceuticals5: PET1
Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [核医学]一般演題 口演
Radiopharmaceuticals5
PET2
Sun. Sep 11, 2022 9:50 AM - 10:50 AM Room6 (Kyoto International Conference Center 2F RoomB-2)
Chair:Masahiro Ono (Kyoto University, Graduate School of Pharmaceutical Sciences), Mitsuyoshi Yoshimoto (Division of Functional Imaging, National Cancer Center)
Kenta Kurimoto1、Sadahiro Naka1,2、Masaharu Wakahara3、Daisuke Kinoshita3、Kazuki Nakasugi3、Hiroki Kato1、Kiichi Ishiwata4,5、Jun Hatazawa6 (1.Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduat e School of Medicine,Osaka,Japan、2.Department of Radiology, Osaka University Hospital,Osaka,Japan、3.SHI Accelerator Sarvice、4.Institute of Cyclotron and Drug Discovery Research, Southern Tohoku Research Institute for Neuroscience、5.Department of Biofunctional Imaging, Fukushima Medical University、6.Reseach center for Nuclear Physics Osaka University)
Hiroki Hashimoto1、Takayuki Ohkubo1,2、Kazunori Kawamura1、Ming-Rong Zhang1 (1.National institutes for Quantum Science and Technology, Chiba, Japan、2.SHI Accelerator Service, Tokyo, Japan)
Yoichi Shimizu1、Tomomi Nobashi2、Yuji Nakamoto1,3 (1.Department of Radiology, Kyoto University Hospital, Kyoto, Japan、2.Department of Preemptive Medicine and Lifestyle Related Disease Research Center, Kyoto University Hospital, Kyoto, Japan、3.Department of Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
Toshimitsu Watanabe1、Ren Iwata2、Shozo Furumoto2、Satoshi Ueno1、Kanako Some1、Hiroki Higuchi1 (1.Sumitomo Heavy Industries, Ltd., Tokyo, Japan、2.Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan)
Takayuki Ohkubo1,2、Masafumi Shimojo3、Maiko Ono3、Masayuki Fujinaga1、Masanao Ogawa1,2、Nobuki Nengaki1,2、Yuji Nagai3、Takafumi Minamimoto3、Makoto Higuchi3、Ming-Rong Zhang1 (1.Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan、2.SHI Accelerator Service Ltd., Tokyo, Japan、3.Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan)